eribulin

Italy

Drugs containing this active substance

  • ERIBULIN ADVANZ PHARMA

    It is an anticancer medicine used in adults for the treatment of metastatic or locally advanced breast cancer (when other therapies have not been effective) and for advanced or metastatic liposarcoma (a tumor of the fatty tissue) after the failure of a previous therapy.

    Form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

    Manufacturer: ADVANZ PHARMA LIMITED

  • ERIBULIN BAXTER

    It is an anticancer drug used in adults for the treatment of locally advanced or metastatic breast cancer (when other therapies have not been effective) and for advanced or metastatic liposarcoma (when a previous therapy has not been effective).

    Form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

    Manufacturer: BAXTER HOLDING BV

  • ERIBULIN EG

    It is an anticancer drug used in adults to treat metastatic or locally advanced breast cancer (when other therapies have not been effective) and advanced or metastatic liposarcoma (a tumor of the fatty tissue) after a previous therapy has failed.

    Form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

    Manufacturer: EG S.P.A.

  • ERIBULIN VIATRISS

    It is an anticancer drug used in adults to treat metastatic or locally advanced breast cancer (when other therapies have not worked) and advanced or metastatic liposarcoma (a tumor of the fatty tissue) after the failure of a previous therapy.

    Form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

    Manufacturer: MYLAN S.P.A.

  • HALAVEN

    It is an anticancer drug used in adults to treat metastatic or locally advanced breast cancer (when other therapies have not worked) and advanced or metastatic liposarcoma (a tumor of the fatty tissue) after a previous therapy has been attempted without success.

    Form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

    Manufacturer: EISAI GMBH

  • MEVLYQ

    It is an anticancer drug used in adults for the treatment of metastatic or locally advanced breast cancer (when other therapies have not been effective) and for advanced or metastatic liposarcoma (a tumor of the fatty tissue) after the failure of a previous therapy.

    Form: solution for injection

    Active substance Dosage
    eribulin -

    ATC: L01XX41

    Manufacturer: YES PHARMACEUTICAL DEVELOPMENT SERVICES GMBH